Home/Vir Biotechnology/Saira Ramasastry
SR

Saira Ramasastry

Director

Vir Biotechnology

Vir Biotechnology Pipeline

DrugIndicationPhase
VIR-2218 + VIR-3434 (Combination)Chronic Hepatitis Delta (HDV)Phase 3
PRO-XTEN® Platform CandidatesUndisclosed Oncology IndicationsPre-clinical